| Name | Title | Contact Details |
|---|
Juventas Therapeutics is a private clinical-stage company developing novel therapies for ischemic cardiovascular disease. The company`s lead product` JVS-100` is a non-viral plasmid that encodes for stromal cell-derived factor-1 (SDF-1). SDF-1 has been shown to significantly increase end-organ function following tissue injury by promoting cell survival` recruiting endogenous stem cells to the damaged region` and promoting new blood vessel growth. The SDF-1 repair pathway is well conserved throughout end-organ systems providing the opportunity to impact a broad range of diseases. Target cardiovascular clinical indications address large markets with high unmet medical need and significant market potential. Juventas is currently enrolling multiple clinical trials to test therapy efficacy in heart failure and critical limb ischemia patients.
AstroPay is an online payment service that enables users to purchase online on international sites.
Cyber Security Works is a leading cybersecurity services company that provides risk-based vulnerability management and penetration services. From infrastructure to code, we test your vulnerabilities and help you remediate them in priority.
ParkourSC digitizes supply chain operations to improve resilience, increase agility, and drive strategic innovation. Our digital supply chain operations platform is powered by next-generation technologies such as hyper-scale graph modeling, AI/ML, and massive real-time data ingestion from IoT and other systems and signals. Customers use ParkourSC to create intelligent digital twins of their supply chain, continuously align planning and execution, foster collaboration across the extended enterprise, and increase profitability by delivering new technology-enabled products, ensuring quality, compliance, and sustainability, and eliminating millions of dollars of waste.